AstraZeneca continued to see strong earnings boosted primarily by its oncology branch, as well as its respiratory and immunology segment.
Trending
- FIFA unveils new Peace Prize ahead of 2026 World Cup draw in Washington
- Bayern Munich’s perfect start makes football history – DW – 11/05/2025
- What does Bihar election mean for Modi’s BJP? – DW – 11/06/2025
- 'Health is the face of climate change': how can cities mitigate the impact of global warming
- UK interest rates set to stay at 4%, but policymakers ‘deeply divided’
- Philippines declares emergency as Kalmaegi death toll soars – DW – 11/06/2025
- Canada unveils ambitious new budget to respond to US tariff shock
- Highlights From the ‘Oscars of Fashion’
